Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Drug Discovery Today|November 19, 2020
Development and economic trends in anticancer drugs licensed in the UK from 2015 to 2019Mark P Lythgoe, Jonathan Krell, Sarah Mahmoud, et al.
Future Oncology (London, England)|December 21, 2012
Is there a 'margin' for error in pancreatic cancer surgery?Adam E Frampton, Tamara M H Gall, Jonathan Krell, et al.
Journal of Clinical Pathology|May 5, 2012
Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathyDaniel G Ezra, Jonathan Krell, Geoffrey E Rose, et al.
Expert Review of Molecular Diagnostics|October 30, 2016
Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancerMireia Mato Prado, Adam E Frampton, Elisa Giovannetti, et al.
Expert Review of Anticancer Therapy|November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 26, 2015
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and diseasePaul Cathcart, Walter Lucchesi, Silvia Ottaviani, et al.
Journal of Clinical Pathology|June 29, 2021
Gene of the month: lymphocyte-activation gene 3 (LAG-3)Mark P Lythgoe, Daniel Si Kit Liu, Nicola E Annels, et al.
Cancers|August 12, 2022
Traditional Systemic Treatment Options in Advanced Low-Grade Serous Ovarian Cancer after Successful Cytoreduction: A Systematic Review and Meta-AnalysisRosa Montero-Macías, Pascal Rigolet, Elie Mikhael, et al.
International Journal of Molecular Sciences|April 12, 2022
The Clinical Significance of Transfer RNAs Present in Extracellular VesiclesDaniel S K Liu, Qi Zhi Clayton Yang, Mohammad Asim, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Drug Discovery Today|November 19, 2020
Development and economic trends in anticancer drugs licensed in the UK from 2015 to 2019Mark P Lythgoe, Jonathan Krell, Sarah Mahmoud, et al.
Future Oncology (London, England)|December 21, 2012
Is there a 'margin' for error in pancreatic cancer surgery?Adam E Frampton, Tamara M H Gall, Jonathan Krell, et al.
Journal of Clinical Pathology|May 5, 2012
Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathyDaniel G Ezra, Jonathan Krell, Geoffrey E Rose, et al.
Expert Review of Molecular Diagnostics|October 30, 2016
Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancerMireia Mato Prado, Adam E Frampton, Elisa Giovannetti, et al.
Expert Review of Anticancer Therapy|November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 26, 2015
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and diseasePaul Cathcart, Walter Lucchesi, Silvia Ottaviani, et al.
Journal of Clinical Pathology|June 29, 2021
Gene of the month: lymphocyte-activation gene 3 (LAG-3)Mark P Lythgoe, Daniel Si Kit Liu, Nicola E Annels, et al.
Cancers|August 12, 2022
Traditional Systemic Treatment Options in Advanced Low-Grade Serous Ovarian Cancer after Successful Cytoreduction: A Systematic Review and Meta-AnalysisRosa Montero-Macías, Pascal Rigolet, Elie Mikhael, et al.
International Journal of Molecular Sciences|April 12, 2022
The Clinical Significance of Transfer RNAs Present in Extracellular VesiclesDaniel S K Liu, Qi Zhi Clayton Yang, Mohammad Asim, et al.
Pageof 14